Tags: cancer

All Categories (41-60 of 101)

  1. KIST/PU Advances in detection systems for biology: Classifying signals from fluorescence and scatter

    08 Dec 2011 | | Contributor(s):: J. Paul Robinson

    Biology-driven advances in photonic detection systems have been dramatic in the last several years. Three specific aspects are of particular interest: molecular detection, cellular detection, and whole-organ or small-animal imaging. Each area of study requires specific probes, detectors, and...

  2. KIST/PU Nanostructured Heparin Derivatives as an Angiogenesis Inhibitor

    07 Dec 2011 | | Contributor(s):: Youngro Byun

    Although low molecular weight heparin (LMWH) has been known to regulate angiogenesis, tumor growth and metastasis, the administration of heparin for treating cancer is limited in clinical application due to its unsatisfactory therapeutic effects and a strong anticoagulant activity, which induces...

  3. KIST/PU 6th Annual Symposium: High Impact Research to Society

    07 Dec 2011 |

    In 2006, the South Korean Ministry of Science and Technology selected the KIST and Purdue team project from 20 international research proposals submitted to examine how to learn more about the molecular makeup of diseases.

  4. KIST/PU The Professor’s Challenge: To commercialize or not, that is the question?

    06 Dec 2011 | | Contributor(s):: J. Paul Robinson

    Outline:Outline the Professors DilemmaShow what the normal criteria for research project direction isDiscuss the Corporate perspectiveDiscuss an example of failed innovationDemonstrate how time can impact an innovative ideaConclusions

  5. KIST/PU Designing a Research Program Around Unmet Clinical Needs

    06 Dec 2011 | | Contributor(s):: Alyssa Panitch

  6. KIST/PU Theragnosis – A New Paradigm of Personalized Medicine

    06 Dec 2011 | | Contributor(s):: Ick Chan Kwon

    Companion Diagnosis, based on pharmacogenomics, has been recognized as one of most important key representatives of personalized medicine. However, Companion Diagnosis does not provide any clues in developing new ways of therapeutics but it only provides a best choice of drugs based on given...

  7. Illinois BioNanotechnology Seminar Series Fall 2011: Deconvolving Stiffness in MEMS Pedestal Cell Mass Measurements

    05 Dec 2011 | | Contributor(s):: Elise Corbin

    The complex relationships between a cell's behavior and the physical properties of both itself and its environment have long been of interest. Specifically, the understanding the mechanisms through which a cell's physical properties influence cell growth, cell differentiation, cell cycle...

  8. Illinois BioNanotechnology Seminar Series Fall 2011: Precisely Size Controlled Drug-silica Nanoconjugate for Cancer Therapy

    05 Dec 2011 | | Contributor(s):: Li Tang

    Drug delivery nanomedicine, exemplified by micelles and nanoparticles roughly in the size range of 1-200 nm, have attracted much interest in the past 2-3 decades as alternative modalities for cancer treatment. The size of these drug delivery vehicles has been strongly correlated with their in...

  9. BME 695L Special Lecture 3: In vivo Model Systems to Study Nanomedical Approaches to Cancer Detection and Intervention

    02 Dec 2011 | | Contributor(s):: Deborah W Knapp

    Guest lecturer: Deborah Knapp.

  10. Illinois 2011 NanoBiophotonics Summer School: Poster Day: Hadiyah Nicole Green

    29 Nov 2011 | | Contributor(s):: Hadiyah Nicole Green, Nadia Jassim

    Cancer laser treatment using gold nanorods.

  11. BME 695L Lecture 13: Designing Nanomedical Systems (NMS) for In-vivo Use

    22 Nov 2011 | | Contributor(s):: James Leary

    See references below for related reading.13.1      Bringing in-vivo considerations into NMS design13.1.1    the in-vitro to ex-vivo to in-vivo paradigm         13.1.1.1 In-vitro - importance of...

  12. BME 695L Lecture 14: Designing and Testing Integrated Nanomedical Systems

    22 Nov 2011 | | Contributor(s):: James Leary

    See references below for related reading.14.1      Introduction to integrated designs14.1.1    “Total design” but there is some order in the design process14.1.2    A brief outline of the total design...

  13. Illinois BioNanotechnology and Nanomedicine: Applications in Cancer and Mechanobiology Lecture 19: How can you tell if a cell is cancerous?

    14 Nov 2011 | | Contributor(s):: Catherine J. Murphy

    Lecture by Catherine Murphy.

  14. Illinois BioNanotechnology and Nanomedicine: Applications in Cancer and Mechanobiology Lecture 20: Nanoparticle contrast agents for tissue

    14 Nov 2011 | | Contributor(s):: Catherine J. Murphy

    Lecture by Catherine Murphy.

  15. Illinois BioNanotechnology and Nanomedicine: Applications in Cancer and Mechanobiology Lecture 22: Mechano-transduction mechanical micro environment determine cell fate

    14 Nov 2011 | | Contributor(s):: Taher A. Saif

    Lecture by Taher Saif.

  16. Illinois BioNanotechnology and Nanomedicine: Applications in Cancer and Mechanobiology Lecture 23: Mechano-transduction mechanical micro environment determine cell fate (examples), possible mechanisms

    14 Nov 2011 | | Contributor(s):: Taher A. Saif

  17. Illinois BioNanotechnology and Nanomedicine: Applications in Cancer and Mechanobiology Lecture 10: Characteristics of a cancer cell

    31 Oct 2011 | | Contributor(s):: Scott Siechen

    Lecture by Scott Siechen.

  18. Illinois BioNanotechnology and Nanomedicine: Applications in Cancer and Mechanobiology Lecture 12: Role of chemicals, radiation, and infectious agents in cancer

    31 Oct 2011 | | Contributor(s):: Ann M Nardulli

  19. Illinois BioNanotechnology and Nanomedicine: Applications in Cancer and Mechanobiology Lecture 13: Role of heredity, oncogenes, and tumor suppressors in cancer

    31 Oct 2011 | | Contributor(s):: Ann M Nardulli

  20. Illinois BioNanotechnology and Nanomedicine: Applications in Cancer and Mechanobiology Lecture 14: Most common cancers in men and women and Quiz

    31 Oct 2011 | | Contributor(s):: Ann M Nardulli